FDA expands approval for Pfizer cancer drug Sutent

(Reuters) - The U.S. Food and Drug Administration on Thursday approved the use of Pfizer Inc's cancer drug Sutent to help prevent kidney cancer from returning following surgical removal of a kidney.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news